Scientists have discovered that taking regular aspirin halves the risk of developing hereditary cancers. The study — which followed nearly 1,000 patients, in some cases for over 10 years — found that those who had been taking a regular dose of aspirin had 50 per cent fewer incidents of hereditary cancer compared with those who were not taking aspirin.